PharmiWeb.com - Global Pharma News & Resources

Medical comms - Press Releases

Date Title Company
27-Sep-2024 CQDM and Epitopea Fund the Development and Validation of CryptoMapTM, a Platform Enabling the Development of RNA-based Immunotherapies Epitopea
27-Sep-2024 LEO Pharma Presents Late-Breaking Results from the Phase 2a Mechanism of Action Trial of Temtokibart and Dupilumab in Moderate-to-Severe Atopic Dermatitis at the 2024 EADV Annual Meeting LEO Pharma A/S
27-Sep-2024 Orion and Aitia enter AI-Driven Drug Discovery and Drug Simulation Collaboration in Oncology Orion Corporation and Aitia
27-Sep-2024 Bayer News - AskBio to collaborate with Belief BioMed to explore the potential of new gene therapies Bayer AG
27-Sep-2024 OMEICOS Therapeutics Completes Enrollment of PMD-OPTION Study in Primary Mitochondrial Disease OMEICOS
27-Sep-2024 DeSci Labs launches novelty scores for scientific manuscripts DeSci Labs
27-Sep-2024 Orion’s collaboration partner Bayer submits application to U.S. FDA for third indication of darolutamide which has become the first ever Orion-originated blockbuster Orion
27-Sep-2024 PolTREG starts preclinical CAR-Treg development for neuroinflammatory autoimmune diseases PolTREG S.A.
27-Sep-2024 SOLARIO study meets its primary endpoints - Bone substitute with local antibiotics enables reduced systemic antibiotic treatment SOLARIO
27-Sep-2024 Pharming announces marketing authorization in the U.K. for Joenja® (leniolisib) Pharming Group N.V.
25-Sep-2024 New data show Almirall´s EBGLYSS® (lebrikizumab) provided sustained disease control for up to three years in more than 80% of adults and adolescents with moderate-to-severe atopic dermatitis Almirall
25-Sep-2024 Semaglutide improves outcomes for obese patients with common skin condition, new study shows European Academy of Dermatology and Venereology (EADV)
25-Sep-2024 Arctoris announces strategic partnership with Alphabet company, Isomorphic Labs Arctoris
25-Sep-2024 Univo IRB Launches Canadian Research Ethics Board Review Services for Clinical Trials in North America Univo IRB
25-Sep-2024 Combination treatment improves response to immunotherapy for lung cancer Francis Crick Institute
25-Sep-2024 Quell Therapeutics expands manufacturing capabilities for CAR-Treg cell therapy pipeline through partnership with eXmoor pharma Quell Therapeutics
25-Sep-2024 Panthera moves back into recruiting and running commercial oncology clinical trials in the UK Panthera Biopartners
25-Sep-2024 Veltassa® (patiromer) approved in Japan for the treatment of adults with hyperkalemia CSL Vifor
25-Sep-2024 Oxford-Harrington Rare Disease Centre to Host Symposium on Pioneering Research and Innovation in Rare Disease Treatments The Oxford-Harrington Rare Disease Centre
25-Sep-2024 HUTCHMED Announces Japan Approval for FRUZAQLA® (fruquintinib) Received by Takeda HUTCHMED